Blog

Plans to Expand U.S. Chip Manufacturing Are Running Into Obstacles

Plans to Expand U.S. Chip Manufacturing Are Running Into Obstacles

In December 2022, Taiwan Semiconductor Manufacturing Company, the key maker of the world’s most cutting-edge chips, said it planned to spend $40 billion in Arizona on its first major U.S. hub for semiconductor production.The much ballyhooed project outside Phoenix — with two new factories, including one with more advanced technology — became a symbol of President Biden’s quest to spur more domestic production of chips, the slices of silicon that help all manner of devices make calculations and store data.Then last summer, TSMC pushed back initial manufacturing at its first Arizona factory to 2025 from this year, saying local workers…
Read More
75 Hard Has a Cultish Following. Is It Worth All the Effort?

75 Hard Has a Cultish Following. Is It Worth All the Effort?

Two 45-minute daily workouts. One gallon of water. 10 pages of a nonfiction book. A diet. No “cheat meals” or alcohol. For 75 days.And if you mess up, you have to start from the beginning.Sound like a lot? It’s supposed to be. The program, called 75 Hard, is meant to build mental toughness. Some say that rigidity is what makes it great, and others say that makes it problematic.Since it was created in 2019, 75 Hard has developed somewhat of a cult following, with practitioners posting daily progress pictures and videos that sometimes rack up millions of views on TikTok…
Read More
OpenAI Completes Deal That Values the Company at  Billion

OpenAI Completes Deal That Values the Company at $80 Billion

OpenAI has completed a deal that values the San Francisco artificial intelligence company at $80 billion or more, nearly tripling its valuation in less than 10 months, according to three people with knowledge of the deal.The company would sell existing shares in a so-called tender offer led by the venture firm Thrive Capital, the people said. The deal lets employees cash out their shares in the company, rather than a traditional funding round that would raise money for business operations.OpenAI, which declined to comment, is now one of the world’s most valuable tech start-ups, behind ByteDance and SpaceX, according to…
Read More
Did You Go Through Fertility Treatment?

Did You Go Through Fertility Treatment?

As women have begun having babies later in life, the number of patients going through in vitro fertilization treatment has increased significantly.The medical treatment can be life-changing, but it also comes at a price, as some couples go deeply into debt to pay for medical care that health insurance does not always cover. Some research has questioned the effectiveness of newer aspects of fertility treatment, like genetic screenings, and some patients have filed lawsuits claiming that faulty chemicals destroyed their embryos. Private equity companies, seeing the industry’s rapid growth, have been buying up some of the country’s largest fertility clinics.The…
Read More
The Antitrust Enforcers Aimed at Big Tech. Then Came the Backlash.

The Antitrust Enforcers Aimed at Big Tech. Then Came the Backlash.

The South Korean government unleashed a wave of panic across the internet industry: The country’s antitrust regulator said it would enact the toughest competition law outside Europe, curbing the influence of major technology companies.The Korea Fair Trade Commission, with the backing of President Yoon Suk Yeol, said in December that it planned to make a proposal modeled after the 2022 Digital Markets Act, the European Union’s landmark law to rein in American tech giants. This bill also seemed to target South Korea’s own internet conglomerates just as much as the Alphabets, Apples and Metas of the world.The commission said the…
Read More
Some Pregnant Women and Infants Received the Wrong R.S.V. Shots

Some Pregnant Women and Infants Received the Wrong R.S.V. Shots

This winter, for the first time ever, there were two vaccines available to ward off respiratory syncytial virus, which is particularly dangerous to older adults and infants. Only one of them — Abrysvo, made by Pfizer — was approved for pregnant women, and neither was for young children.The distinction apparently slipped by some clinicians and pharmacists.At least 128 pregnant women were mistakenly given the alternative vaccine — Arexvy, by GSK — and at least 25 children under age 2 received a vaccination, the Centers for Disease Control and Prevention has warned. Dr. Sarah Long, a pediatric infectious disease physician and…
Read More